| ASSET | QUARTER | % RETURN |
|---|---|---|
Arena (AREN) | Q2 2004 | 16,357.26% |
Oramed Pharmaceuticals (ORMP) | Q2 2004 | 4,130% |
Cemtrex (CETX) | Q2 2004 | 600.55% |
Cytokinetics (CYTK) | Q2 2004 | 493.99% |
Worksport (WKSP) | Q2 2004 | 292.16% |
Travelzoo (TZOO) | Q2 2004 | 259.35% |
Insteel Industries (IIIN) | Q2 2004 | 244% |
Nocera (NCRA) | Q2 2004 | 233.33% |
TherapeuticsMD (TXMD) | Q2 2004 | 204.76% |
Alto Ingredients (ALTO) | Q2 2004 | 165.91% |
Evolution Petroleum (EPM) | Q2 2004 | 152.72% |
CryoCell International (CCEL) | Q2 2004 | 146.05% |
Air T (AIRT) | Q2 2004 | 139.23% |
PowerFleet (AIOT) | Q2 2004 | 128.33% |
Smart Powerr (CREG) | Q2 2004 | 123.34% |
Hallador Energy (HNRG) | Q2 2004 | 122.23% |
Anika Therapeutics (ANIK) | Q2 2004 | 109.3% |
CBAK Energy Technology (CBAT) | Q2 2004 | 102% |
Sanara Medtech (SMTI) | Q2 2004 | 100% |
Titan International (TWI) | Q2 2004 | 96.85% |
LifeMD (LFMD) | Q2 2004 | 86.67% |
Dawson Geophysical (DWSN) | Q2 2004 | 86.14% |
Red Cat (RCAT) | Q2 2004 | 85.71% |
ANI Pharmaceuticals (ANIP) | Q2 2004 | 85.3% |
China Pharma (CPHI) | Q2 2004 | 83.33% |